Shane V. Hegarty
Has grant
Chief Scientific Officer & Co-Founder
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Shane V. Hegarty is the Chief Scientific Officer and Co-Founder at AXONIS Therapeutics, Inc., based in the United States. His research focuses on lipidomics, stem cell biology, epigenetics, and the molecular pathways involved in neuroblastoma and Parkinson's disease. Recent publications address topics such as optic nerve regeneration, the role of microRNAs, and neuronal cell type-specific visualization techniques.
Recent Grants
Grant: Close
Characterizing the role of a novel kinase in neuronal survival and regeneration after CNS injury
Open Date: 2020-01-01
Close Date: 2020-12-01
Grant: Close
Royal Irish Academy Charlemont Grant 2016
Open Date: 2016-05-01
Close Date: 2016-07-01
Grant: Close
NUI Post-Doctoral Research Fellowship in the Sciences
Open Date: 2015-10-01
Close Date: 2016-09-01
Grant: Close
New Foundations Award 2014
Open Date: 2015-03-01
Close Date: 2015-09-01
Grant: Close
Government of Ireland Post-Doctoral Fellowship
Open Date: 2014-10-01
Close Date: 2015-10-01
Articles (4)
Year:
2020
Year:
2020
Year:
2020
Year:
2020
Collaborators (1)
Sean Wyatt
Senior Lecturer
Cardiff University
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.